ASEM documentary overview
Official Canadian Paediatric Society document (2023) on “Medical cannabis for children: Evidence and recommendations”. Interest in using cannabis products for a medical purpose in children under the age of 18 years is increasing. There are many medical cannabis products available that can include cannabidiol (CBD) or delta-9-tetrahydrocannabinol (THC), or both cannabinoids. Despite many therapeutic claims, there are few rigorous studies to inform the dosing, safety, and efficacy of medical cannabis used in paediatric clinical practic.
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document